6-152430143-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.4757C>A​(p.Thr1586Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00443 in 1,602,944 control chromosomes in the GnomAD database, including 168 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1586A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0063 ( 20 hom., cov: 33)
Exomes 𝑓: 0.0042 ( 148 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 4.38

Publications

10 publications found
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
SYNE1 Gene-Disease associations (from GenCC):
  • autosomal recessive ataxia, Beauce type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • arthrogryposis multiplex congenita 3, myogenic type
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Emery-Dreifuss muscular dystrophy 4, autosomal dominant
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive myogenic arthrogryposis multiplex congenita
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025706887).
BP6
Variant 6-152430143-G-T is Benign according to our data. Variant chr6-152430143-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.062 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE1NM_182961.4 linkc.4757C>A p.Thr1586Lys missense_variant Exon 36 of 146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkc.4757C>A p.Thr1586Lys missense_variant Exon 36 of 146 1 NM_182961.4 ENSP00000356224.5 Q8NF91-1
SYNE1ENST00000423061.6 linkc.4778C>A p.Thr1593Lys missense_variant Exon 36 of 146 1 ENSP00000396024.1 A0A0C4DG40
SYNE1ENST00000461872.6 linkn.4975C>A non_coding_transcript_exon_variant Exon 34 of 55 1
SYNE1ENST00000367253.8 linkc.4757C>A p.Thr1586Lys missense_variant Exon 34 of 36 5 ENSP00000356222.4 Q8NF91-6

Frequencies

GnomAD3 genomes
AF:
0.00626
AC:
952
AN:
152036
Hom.:
19
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0316
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.0368
Gnomad SAS
AF:
0.00310
Gnomad FIN
AF:
0.0111
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000956
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.0108
AC:
2573
AN:
238176
AF XY:
0.00897
show subpopulations
Gnomad AFR exome
AF:
0.000985
Gnomad AMR exome
AF:
0.0418
Gnomad ASJ exome
AF:
0.00526
Gnomad EAS exome
AF:
0.0351
Gnomad FIN exome
AF:
0.0110
Gnomad NFE exome
AF:
0.000904
Gnomad OTH exome
AF:
0.00767
GnomAD4 exome
AF:
0.00424
AC:
6152
AN:
1450792
Hom.:
148
Cov.:
30
AF XY:
0.00406
AC XY:
2931
AN XY:
721104
show subpopulations
African (AFR)
AF:
0.000751
AC:
25
AN:
33310
American (AMR)
AF:
0.0415
AC:
1836
AN:
44202
Ashkenazi Jewish (ASJ)
AF:
0.00457
AC:
118
AN:
25832
East Asian (EAS)
AF:
0.0640
AC:
2524
AN:
39416
South Asian (SAS)
AF:
0.00366
AC:
311
AN:
85064
European-Finnish (FIN)
AF:
0.0113
AC:
599
AN:
52826
Middle Eastern (MID)
AF:
0.000874
AC:
5
AN:
5722
European-Non Finnish (NFE)
AF:
0.000426
AC:
471
AN:
1104592
Other (OTH)
AF:
0.00440
AC:
263
AN:
59828
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
283
566
849
1132
1415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00627
AC:
954
AN:
152152
Hom.:
20
Cov.:
33
AF XY:
0.00759
AC XY:
565
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41534
American (AMR)
AF:
0.0317
AC:
484
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3468
East Asian (EAS)
AF:
0.0371
AC:
192
AN:
5178
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4828
European-Finnish (FIN)
AF:
0.0111
AC:
117
AN:
10564
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000956
AC:
65
AN:
67980
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
47
94
140
187
234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00277
Hom.:
10
Bravo
AF:
0.00809
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000682
AC:
3
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00844
AC:
1023
Asia WGS
AF:
0.0220
AC:
77
AN:
3462

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Nov 08, 2023
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

May 24, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 14, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SYNE1: BP4, BS1, BS2 -

Autosomal recessive ataxia, Beauce type Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant;C5193121:Arthrogryposis multiplex congenita 3, myogenic type Benign:1
Apr 25, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
22
DANN
Benign
0.95
DEOGEN2
Benign
0.20
T;.;T;.
Eigen
Benign
0.047
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.91
D;T;D;D
MetaRNN
Benign
0.0026
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M;.;.;M
PhyloP100
4.4
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.4
N;.;N;N
REVEL
Benign
0.13
Sift
Uncertain
0.017
D;.;D;T
Sift4G
Uncertain
0.0060
D;D;D;D
Polyphen
0.049
B;.;.;B
Vest4
0.25
MPC
0.19
ClinPred
0.021
T
GERP RS
6.0
Varity_R
0.27
gMVP
0.14
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77675624; hg19: chr6-152751278; COSMIC: COSV55142609; COSMIC: COSV55142609; API